DaShenLin Pharmaceutical Group. (603233.SHG) Q2 2026 Earnings

Apr 24Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.18
0.27
0.36
0.45

Details

Expected EPS
0.431749904391717
Actual EPS
0.44582714414999997
Surprise EPS
0.01
Surprise Percent
+3.26%

Description

⁨DaShenLin Pharmaceutical Group.⁩ (⁦603233.SHG⁩) has reported earnings of ⁦0.44582714414999997⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts